NFKB2 is a key component of the non-canonical NF-κB pathway, and this pathway activity (assessed by NIK, IKKα and RelB staining) was shown to be associated with poor survival in ccRCC patients [29]. Here, RELB is linked to nonpapillary renal cell carcinoma.